doi:10.14797/MDCVJ.687Laura GerikHouston Methodist DeBakey Heart & Vascular Center
Atrium Health Sanger Heart & Vascular Institute Performs Landmark Heart Valve Surgery June 10, 2024 —Atrium Health Sanger Heart & Vascular Institutehas successfully completed the first commercial ... June 10, 2024 VIDEOS DAIC Thought Leadership Series: The Importance of Inclusion in Clinical Trials...
Nancy Albert Associate Chief Nursing Officer, Research and Innovation- Nursing Institute and Clinical Nurse Specialist, Kaufman Center for Heart Failure- Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland OH Amgen, AstraZeneca, Boston Scientific, Merck, Novartis None None None None None...
Advanced Heart Failure, Transplant, DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, United States Mitchell Psotka, MD, PhD Heart Failure, Transplant, Inova Heart and Vascular Institute, Falls Church, Virginia, United States ...
Associate Clinical Professor of Cardiothoracic and Vascular Surgery with the University of Texas Health Science Center of Houston. – September 2001 to January 2010 President of the Harris County Medical Society-Western Branch. – January 2007 to December 2007 ...
Paul's Hospital, Vancouver, British Columbia, Canada; Department of Cardiology, Houston Methodist Hospital, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA; Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA...
c Center for Advanced Heart Failure, Memorial Hermann Heart and Vascular Institute, The University of Texas Health Science Center at Houston, Houston, TX, USA Received 8 February 2015, Revised 20 May 2015, Accepted 9 June 2015, Available online 19 June 2015Abstract...
Heart failure: mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention. FASEB J. 1990;4(13):3068–75. CAS PubMed Google Scholar Cohn JN. Rationale for angiotensin II receptor blocker therapy in chronic heart failure. J Renin Angiotensin Aldosterone Syst. ...
Corresponding Author: JoAnn Lindenfeld, MD, Advanced Heart Failure, Vanderbilt Heart and Vascular Institute, 1215 21st Ave S, Ste 5309, Nashville, TN 37232 (joann.lindenfeld@vumc.org). Author Contributions: Dr Stone had full access to all of the data in the study and takes responsibility for ...
(MLK-3), is essential for both activation of the mitogen-activated protein kinases and entry into the cell cycle by growth-promoting stimuli. These data have important implications for the treatment of disorders that involve unrestrained growth of vascular smooth muscle cells and other cells, ...